Neri, P., Ren, L., Gratton, K., Stebner, E., Johnson, J., Klimowicz, A., . . . Bahlis, N. J. (2011). Bortezomib-induced “BRCAness” sensitizes multiple myeloma cells to PARP inhibitors. Blood.
Chicago ZitierstilNeri, Paola, et al. "Bortezomib-induced “BRCAness” Sensitizes Multiple Myeloma Cells to PARP Inhibitors." Blood 2011.
MLA ZitierstilNeri, Paola, et al. "Bortezomib-induced “BRCAness” Sensitizes Multiple Myeloma Cells to PARP Inhibitors." Blood 2011.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.